The end of our Knowledge Updates is nigh!

Because of our new KnowledgeShare Evidence Update service, we will be ceasing the existing Knowledge Update bulletins at the end of February.

All subscribers to Knowledge Updates should have received an email, so this is just a reminder to make sure you sign up soon to the KnowledgeShare Evidence Update service to ensure you continue to receive updates of new evidence from the library.

The big advantage of the new service is that it is more tailored to your specific interests, and personalisation of library services is an objective of the national Knowledge for Healthcare strategy.

We’ve been running the Knowledge Update service since 2009, and still have subscribers who have been receiving the bulletins since then. We had over 800 subscribers and 45 bulletins, but it was becoming increasingly unwieldy to manage, and was at risk from the potential loss of tools such as Feed.Informer that we used to combine RSS feeds, and Google Feedburner that we used to manage subscriptions. The service also relied on RSS feeds and these are not as well supported as they once were, with many sites no longer providing them.

We’ll be sad to see the old service discontinued, but we believe the new KnowledgeShare Evidence Update service is even better!

Posted in News Tagged with: ,

Subscribe to library updates

Enter your email address to be alerted when new items are posted:

Delivered by FeedBurner

  • NHS Choices
    Health A-Z Symptoms, conditions, medicines, treatments and guides Find conditions and treatments Live well Articles, videos and tools from the NHS on more than 100 topics, including alcohol, diet, fitness, tiredness and weight loss, giving you and your family tips on healthy living. Visit healthy living information Common Health Questions A comprehensive list of common […]
  • Cancer treatment response may be affected by gut bacteria
    "Gut bacteria 'boost' cancer therapy," BBC News reports. The news comes from research into whether people with cancer might respond differently to cancer treatment depending on the bacteria in their gut. Researchers specifically looked at a type of cancer treatment called immunotherapy. This involves stimulating the immune system to attack cancerous cells – in this […]
  • Could a blood test in middle age predict dementia risk?
    "Tissue inflammation blood test points to dementia risk," is the headline in The Times. Researchers in the US say people who have higher measures of inflammation in middle age are likely to have less brain tissue in some parts of their brain in older age. The differences in brain volume, seen on MRI scans, were […]
  • Acid reflux drugs linked to increased stomach cancer risk
    "A drug commonly used to treat acid reflux is linked to a more than doubled risk of developing stomach cancer," reports The Guardian. Researchers wanted to investigate whether there's a link between medicines known as proton pump inhibitors (PPIs) and stomach cancer. Widely used PPIs include esomeprazole, lansoprazole, omeprazole, pantoprazole and rabeprazole. PPIs are used […]
  • Nutrient drink for Alzheimer's has disappointing result in trial
    A new study investigating the effects of a nutrient drink for Alzheimer's disease has led to very different headlines in the media. While BBC News tells us the "Alzheimer's nutrient drink falters in clinical trial", the Daily Mirror reports the drink "could help stave off Alzheimer's disease, according to scientists". The trial investigated the effects […]